Skip to content
Benchmarking commonly used software suites and analysis workflows for DIA proteomics and phosphoproteomics

A recent study using IonOpticks Aurora Series Columns compares the performance of widely used software and workflows for data-independent acquisition (DIA) proteomics and phosphoproteomics. The researchers generated a reference dataset for benchmarking and evaluated four popular software suites using various metrics. The results indicated that different software suites exhibit distinct strengths and weaknesses depending on the type of experiment, and there is no single “best” software for all DIA proteomics and phosphoproteomics applications. The researchers also provided recommendations for selecting software based on experimental needs and outlined the importance of transparency and reproducibility in DIA proteomics and phosphoproteomics research. Overall, this study provides valuable insights for researchers seeking to optimize their DIA proteomics and phosphoproteomics analyses. https://www.nature.com/articles/s41467-022-35740-1


The effectiveness of the IonOpticks Aurora 25cm column in establishing a robust and dependable method for proteomic analysis is underscored in this research.

Journal Article – Jan 2023  – Nature Communications

Authors 

R. Lou; Y. Cao; S. Li; X. Lang; Y. Li; Y. Zhang; W. Shui

Title

Benchmarking commonly used software suites and analysis workflows for DIA proteomics and phosphoproteomics

Share:

Related publications & news

IonOpticks is strengthening its APACI & MEA leadership with the appoint...
FOR IMMEDIATE RELEASE Melbourne, Australia / Pennsylvania, US / July 24, 20...
FOR IMMEDIATE RELEASE Melbourne, Australia / Milton, United Kingdom / July ...
The Agreement will bring Aurora Series® XS columns and the HeatSync™ eco...
OPINION | Dr Jarrod Sandow, Chief Product Officer For as long as I have wor...
Assistant Professor Luke Gamon, at the University of Copenhagen, is rethink...
Melbourne, Australia – IonOpticks, developer of the highest-performin...
FOR IMMEDIATE RELEASE Melbourne, Australia – 05 November, 2025 – IonOpt...
Previous
Next